The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
The relationship between inflammation and venous thrombosis: A systematic review of clinical studies
Abstract
Summary: During the past decade, the role of inflammation in the pathophysiology of arterial thrombosis has been elucidated. However, comparatively little is known about the relationship between inflammation and venous thrombosis. The aim of this study was to perform a systematic review of clinical studies that have examined the association between inflammation and venous thrombosis, specifically: (1) the value of inflammatory markers in predicting the future development of venous thrombosis; (2) test characteristics of markers of inflammation in the diagnosis of acute venous thrombosis; and (3) effect of venous thrombosis on blood levels of inflammatory markers. Using keywords venous thrombosis, venous thromboembolism, inflammation, acute phase markers, C-reactive protein (CRP), interleukin (IL)-6, IL-8, and monocyte chemotactic protein (MCP)-1, PubMed and Medline computerized databases were searched for English language articles published after 1980. Search results were restricted to clinical studies in humans that used study designs that were appropriate to address the above objectives. Results show that plasma CRP levels do not appear to predict risk of future venous thtwo (rombosis studies; N=41,308). Four studies (N=562) have examined the utility of plasma CRP in the diagnosis of venous thrombosis; pooled positive and negative predictive values were 53% (95% CI:47%,59%) and 85% (95% CI: 81%, 89%), respectively.A two- to six-fold increase in the risk of deep vein thrombosis (DVT) is associated with elevations in plasma levels of CRP, IL-6, IL-8, MCP-1 orTNF-α (three studies). We can conclude that the nature of the relationship between inflammation and clinical venous thrombosis is not yet established. CRP does not appear to be useful in predicting future venous thrombosis or in the diagnosis of acute venous thrombosis. While several markers of inflammation are elevated in acute venous thrombosis, further research is needed to determine the precise relationship between these markers and venous thrombosis. The identification and elucidation of inflammatory markers relevant to venous thrombosis could provide targets for future therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men
Ridker, P. M., Cushman, M., Stampfer, M. J., Tracy, R. P., & Hennekens, C. H. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704033361401 · Cited by 5,504
Silverstein, M. D., Heit, J. A., Mohr, D. N., Petterson, T. M., O'Fallon, W. M., & Melton, L. J. (1998) · Archives of Internal Medicine · doi:10.1001/archinte.158.6.585 · Cited by 2,660
Risk Factors for Venous Thromboembolism
Anderson, F. A., & Spencer, F. A. (2003) · Circulation · doi:10.1161/01.cir.0000078469.07362.e6 · Cited by 1,652
Koster, T., Vandenbroucke, J. P., Rosendaal, F. R., Briët, E., Rosendaal, F. R., & Blann, A. D. (1995) · The Lancet · doi:10.1016/s0140-6736(95)90166-3 · Cited by 1,131 · cited 1×
“Elevated plasma Factor VIII:C (FVIII:C) is a risk factor for VTE (11, 12).”
BackgroundC-reactive protein induces human peripheral blood monocytes to synthesize tissue factor
Cermak, J., Key, N., Bach, R., Balla, J., Jacob, H., & Vercellotti, G. (1993) · Blood · doi:10.1182/blood.v82.2.513.513 · Cited by 839
Activation of Coagulation after Administration of Tumor Necrosis Factor to Normal Subjects
van der Poll, T., Büller, H. R., ten Cate, H., Wortel, C. H., Bauer, K. A., van Deventer, S. J. H., Hack, C. E., Sauerwein, H. P., Rosenberg, R. D., & ten Cate, J. W. (1990) · New England Journal of Medicine · doi:10.1056/nejm199006073222302 · Cited by 667
Verma, S., Li, S.-H., Badiwala, M. V., Weisel, R. D., Fedak, P. W. M., Li, R.-K., Dhillon, B., & Mickle, D. A. G. (2002) · Circulation · doi:10.1161/01.cir.0000015126.83143.b4 · Cited by 634
High Plasma Concentration of Factor VIIIc Is a Major Risk Factor for Venous Thromboembolism
in 't Anker, P., Koopman, M., Reitsma, P., Prins, M., van den Ende, A., Büller, H., & Kraaijenhagen, R. (2000) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1613747 · Cited by 489
Tsai, A. W., Cushman, M., Rosamond, W. D., Heckbert, S. R., Tracy, R. P., Aleksic, N., & Folsom, A. R. (2002) · The American Journal of Medicine · doi:10.1016/s0002-9343(02)01345-1 · Cited by 376
Kamphuisen, P., Eikenboom, J., Vos, H., Pablo, R., Sturk, A., Rosendaal, F., & Bertina, R. (1999) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1614553 · Cited by 259
O’Donnell, J., Tuddenham, E. G. D., Manning, R., Kemball-Cook, G., Johnson, D., & Laffan, M. (1997) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1656061 · Cited by 228
Mumford, A., Manning, R., Laffan, M., & O’Donnell, J. (2000) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1613748 · Cited by 208
Inflammatory response in the acute phase of deep vein thrombosis
Roumen-Klappe, E. M., den Heijer, M., van Uum, S. H. M., van der Ven-Jongekrijg, J., van der Graaf, F., & Wollersheim, H. (2002) · Journal of Vascular Surgery · doi:10.1067/mva.2002.121746 · Cited by 175
Recurrent Venous Thrombosis and Markers of Inflammation
van Aken, B. E., den Heijer, M., Bos, G. M. J., van Deventer, S. J. H., & Reitsma, P. H. (2000) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1613858 · Cited by 144
Activation of innate immunity in patients with venous thrombosis: the Leiden Thrombophilia Study
Reitsma, P. H., & Rosendaal, F. R. (2004) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2004.00689.x · Cited by 136
Interleukin 8 and venous thrombosis: evidence for a role of inflammation in thrombosis
van Aken, B. E., Reitsma, P. H., & Rosendaal, F. R. (2002) · British Journal of Haematology · doi:10.1046/j.1365-2141.2002.03245.x · Cited by 119
Pathogenesis of Venous Thrombosis: A New Insight
Wakefield, T. W., Strieter, R. M., Prince, M. R., Downing, L. J., & Greenfield, L. J. (1997) · Cardiovascular Surgery · doi:10.1016/s0967-2109(96)00083-x · Cited by 81
Acute phase reaction, fibrinogen level and thrombus size
Chooi, C. C., & Gallus, A. S. (1989) · Thrombosis Research · doi:10.1016/0049-3848(89)90204-1 · Cited by 48
Cited by
Konstantinides, S. V., Meyer, G., Becattini, C., Bueno, H., Geersing, G.-J., Harjola, V.-P., Huisman, M. V., Humbert, M., Jennings, C. S., Jiménez, D., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehz405 · Cited by 4,916
2014 ESC Guidelines on the diagnosis and management of acute pulmonary embolism
Authors/Task Force Members, Konstantinides, S. V., Torbicki, A., Agnelli, G., Danchin, N., Fitzmaurice, D., Galiè, N., Gibbs, J. S. R., Huisman, M. V., Humbert, M., et al. (2014) · European Heart Journal · doi:10.1093/eurheartj/ehu283 · Cited by 3,128
Konstantinides, S. V., Meyer, G., Becattini, C., Bueno, H., Geersing, G.-J., Harjola, V.-P., Huisman, M. V., Humbert, M., Jennings, C. S., Jiménez, D., et al. (2019) · European Respiratory Journal · doi:10.1183/13993003.01647-2019 · Cited by 1,619
Chronic Thromboembolic Pulmonary Hypertension
Hoeper, M. M., Mayer, E., Simonneau, G., & Rubin, L. J. (2006) · Circulation · doi:10.1161/circulationaha.105.602565 · Cited by 1,148
Prevention of thalidomide- and lenalidomide-associated thrombosis in myeloma
Palumbo, A., Rajkumar, S. V., Dimopoulos, M. A., Richardson, P. G., San Miguel, J., Barlogie, B., Harousseau, J., Zonder, J. A., Cavo, M., Zangari, M., et al. (2008) · Leukemia · doi:10.1038/sj.leu.2405062 · Cited by 840
Metadata
- Authors
- Fox, E. A., & Kahn, S. R.
- Venue
- Thrombosis and Haemostasis
- Publisher
- Georg Thieme Verlag KG
- Published
- 2005
- Volume
- 94
- Issue
- 08
- Pages
- 362-365
- ISSN
- 0340-6245 (ISSN-L)
- 2567-689X
- OpenAlex
- W2080791679
- Cited by
- 275
- References
- 18
- FWCI
- 6.46
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.